Skip to main content
. 2022 Apr 29;10(5):1032. doi: 10.3390/biomedicines10051032

Figure 5.

Figure 5

Empagliflozin regulates Hippo signalling in LX-2 cells. (a) Following different doses of EMPA treatment in LX-2 cells for 12 h, the protein levels of MST1, MST2, phospho-MST1/2, MOB1, phospho-MOB1, LATS1, and phospho-LATS1 were evaluated via Western blot. (b) Statistical analysis on the relative expression of the Hippo pathway in LX-2 cells. Data are expressed as means ± standard deviation of three independent experiments. * p < 0.05, ** p < 0.01, and *** p < 0.001 compared to the control.